blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1305025

EP1305025 - PHARMACEUTICAL COMPOSITION COMPRISING METFORMIN AND A 5-PHENOXYALKYL-2,4-THIAZOLIDINEDIONE-TYPE DERIVATIVE [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  17.06.2005
Database last updated on 19.10.2024
Most recent event   Tooltip17.06.2005Application deemed to be withdrawnpublished on 03.08.2005  [2005/31]
Applicant(s)For all designated states
Merck Patent GmbH
Frankfurter Strasse 250
64293 Darmstadt / DE
[N/P]
Former [2003/18]For all designated states
MERCK PATENT GmbH
Frankfurter Strasse 250
64293 Darmstadt / DE
Inventor(s)01 / MOINET, Gérard
15, rue Lamartine
F-91400 Orsay / FR
02 / BOTTON, Gérard
9bis, rue du Haras
F-78530 Buc / FR
03 / MESANGEAU, Didier
5 rue Auguste Renoir
F-77380 Combs La Ville / FR
 [2003/18]
Application number, filing date01960539.324.07.2001
[2003/18]
WO2001EP08512
Priority number, dateFR2000001036204.08.2000         Original published format: FR 0010362
[2003/18]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO0211721
Date:14.02.2002
Language:EN
[2002/07]
Type: A1 Application with search report 
No.:EP1305025
Date:02.05.2003
Language:EN
The application published by WIPO in one of the EPO official languages on 14.02.2002 takes the place of the publication of the European patent application.
[2003/18]
Search report(s)International search report - published on:EP14.02.2002
ClassificationIPC:A61K31/425, A61P7/00, // A61K31:425, A61K31:155
[2003/18]
CPC:
A61K31/425 (EP,US); A61K31/426 (KR); A61P3/10 (EP);
A61P7/00 (EP); A61P7/12 (EP)
C-Set:
A61K31/425, A61K2300/00 (US,EP);
A61K31/425, A61K31/155 (EP,US)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2003/18]
Extension statesALNot yet paid
LT06.12.2002
LV06.12.2002
MKNot yet paid
RO06.12.2002
SI06.12.2002
TitleGerman:PHARMAZEUTISCHE ZUSAMMENSETZUNG ENTHALTEND METFORMIN UND EIN 5-PHENOXYALKYL-2,4-THIAZOLIDINDION-TYP DERIVAT[2003/18]
English:PHARMACEUTICAL COMPOSITION COMPRISING METFORMIN AND A 5-PHENOXYALKYL-2,4-THIAZOLIDINEDIONE-TYPE DERIVATIVE[2003/18]
French:COMPOSITION PHARMACEUTIQUE COMPRENANT DE LA METFORMINE ET UN DERIVE DE TYPE 5-PHENOXYALKYLE-2,4-THIAZOLIDINEDIONE[2003/18]
Entry into regional phase06.12.2002National basic fee paid 
06.12.2002Designation fee(s) paid 
06.12.2002Examination fee paid 
Examination procedure13.02.2002Request for preliminary examination filed
International Preliminary Examining Authority: EP
06.12.2002Examination requested  [2003/18]
01.02.2005Application deemed to be withdrawn, date of legal effect  [2005/31]
07.03.2005Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2005/31]
Fees paidRenewal fee
14.07.2003Renewal fee patent year 03
Penalty fee
Additional fee for renewal fee
31.07.200404   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[DA]WO9857634  (SMITHKLINE BEECHAM PLC [GB], et al) [DA] 1,2,5 * claims 1-3 * * page 2, lines 25-30 *;
 [A]WO9903477  (SMITHKLINE BEECHAM PLC [GB], et al) [A] 1,2,5 * claims 1,3,13 *;
 [A]  - M.RIDDLE, "Combining sulfonylureas and other agents", AMERICAN JOURNAL OF MEDICINE, (2000), vol. 108, no. suppl. 6A, pages 15S - 22S, XP001002376 [A] 1,2,5 * page 15S * * page 16S *

DOI:   http://dx.doi.org/10.1016/S0002-9343(00)00338-7
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.